239 related articles for article (PubMed ID: 17323596)
21. BiDil (isosorbide dinitrate and hydralazine): a new fixed-dose combination of two older medications for the treatment of heart failure in black patients.
Carmody MS; Anderson JR
Cardiol Rev; 2007; 15(1):46-53. PubMed ID: 17172884
[TBL] [Abstract][Full Text] [Related]
22. Isosorbide dinitrate and hydralazine in a fixed-dose combination produces further regression of left ventricular remodeling in a well-treated black population with heart failure: results from A-HeFT.
Cohn JN; Tam SW; Anand IS; Taylor AL; Sabolinski ML; Worcel M;
J Card Fail; 2007 Jun; 13(5):331-9. PubMed ID: 17602978
[TBL] [Abstract][Full Text] [Related]
23. Isosorbide dinitrate-hydralazine improves outcomes in African Americans with heart failure.
Colvin-Adams M; Taylor AL
Cleve Clin J Med; 2007 Mar; 74(3):227-34. PubMed ID: 17375804
[TBL] [Abstract][Full Text] [Related]
24. The isosorbide-hydralazine story: is there a case for race-based cardiovascular medicine?
Ferdinand KC
J Clin Hypertens (Greenwich); 2006 Mar; 8(3):156-8. PubMed ID: 16522991
[No Abstract] [Full Text] [Related]
25. Cost-effectiveness of fixed-dose combination of isosorbide dinitrate and hydralazine therapy for blacks with heart failure.
Angus DC; Linde-Zwirble WT; Tam SW; Ghali JK; Sabolinski ML; Villagra VG; Winkelmayer WC; Worcel M;
Circulation; 2005 Dec; 112(24):3745-53. PubMed ID: 16344404
[TBL] [Abstract][Full Text] [Related]
26. Fixed-dose isosorbide dinitrate-hydralazine: race-based cardiovascular medicine benefit or mirage?
Ferdinand KC
J Law Med Ethics; 2008; 36(3):458-63. PubMed ID: 18840236
[TBL] [Abstract][Full Text] [Related]
27. Heart failure in African Americans: disparities can be overcome.
Sharma A; Colvin-Adams M; Yancy CW
Cleve Clin J Med; 2014 May; 81(5):301-11. PubMed ID: 24789589
[TBL] [Abstract][Full Text] [Related]
28. Underuse of hydralazine and isosorbide dinitrate for heart failure in patients of African ancestry: a cross-European survey.
Brewster LM
ESC Heart Fail; 2019 Jun; 6(3):487-498. PubMed ID: 30892835
[TBL] [Abstract][Full Text] [Related]
29. Nitroso-redox balance in the cardiovascular system.
Hare JM
N Engl J Med; 2004 Nov; 351(20):2112-4. PubMed ID: 15533853
[No Abstract] [Full Text] [Related]
30. Effect of fixed-dose combined isosorbide dinitrate/hydralazine in elderly patients in the African-American heart failure trial.
Taylor AL; Sabolinski ML; Tam SW; Ziesche S; Ghali JK; Archambault WT; Worcel M; Cohn JN;
J Card Fail; 2012 Aug; 18(8):600-6. PubMed ID: 22858074
[TBL] [Abstract][Full Text] [Related]
31. Dilemmas With Race and Heart Failure Treatment.
Butler J; Konstam MA
Circ Heart Fail; 2016 Oct; 9(10):. PubMed ID: 27707751
[No Abstract] [Full Text] [Related]
32. Editorial commentary on fixed combination isosorbide dinitrate/hydralazine for nitric-oxide-enhancing therapy in heart failure.
Flack JM
Expert Opin Pharmacother; 2007 Feb; 8(3):275-7. PubMed ID: 17266462
[TBL] [Abstract][Full Text] [Related]
33. BiDil: from another vantage point.
Puckrein G
Health Aff (Millwood); 2006; 25(5):w368-74. PubMed ID: 16912053
[TBL] [Abstract][Full Text] [Related]
34. Novel heart failure drug may offer options for you.
Heart Advis; 2005 Sep; 8(9):2. PubMed ID: 16637097
[No Abstract] [Full Text] [Related]
35. BiDil (isosorbide dinitrate and hydralazine hydrochloride).
Sica DA
Congest Heart Fail; 2006; 12(2):110-1. PubMed ID: 16596047
[No Abstract] [Full Text] [Related]
36. Have we witnessed the rise and fall of race-specific drugs?
Coons SJ
Clin Ther; 2009 Mar; 31(3):620-2. PubMed ID: 19393852
[No Abstract] [Full Text] [Related]
37. Isosorbide dinitrate and hydralazine hydrochloride: a review of efficacy and safety.
Ferdinand KC
Expert Rev Cardiovasc Ther; 2005 Nov; 3(6):993-1001. PubMed ID: 16292990
[TBL] [Abstract][Full Text] [Related]
38. Combination of Hydralazine and Isosorbide-Dinitrate in the Treatment of Patients with Heart Failure with Reduced Ejection Fraction.
Nyolczas N; Dékány M; Muk B; Szabó B
Adv Exp Med Biol; 2018; 1067():31-45. PubMed ID: 29086392
[TBL] [Abstract][Full Text] [Related]
39. Race and a heart drug.
Peota C
Minn Med; 2005 Mar; 88(3):11. PubMed ID: 15852585
[No Abstract] [Full Text] [Related]
40. Hydralazine and isosorbide dinitrate in heart failure: historical perspective, mechanisms, and future directions.
Cole RT; Kalogeropoulos AP; Georgiopoulou VV; Gheorghiade M; Quyyumi A; Yancy C; Butler J
Circulation; 2011 May; 123(21):2414-22. PubMed ID: 21632515
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
